Adaptation of cells and tissues to ischemia or hypoxia is of fundamental importance in developmental, physiological, and pathophysiological processes. Cells, tissues, and organs of humans and other mammals respond to low oxygen tension in part by finely tuned expression of a group of physiologically relevant genes, proteins, and enzymes. The microsomal heme oxygenase (HO), originally identified by Tenhunen et al.,
3 catalyzes the oxidative degradation of heme to biliverdin, which is subsequently converted to bilirubin by biliverdin reductase.
3 4 Mammalian heme oxygenase, which catabolizes cellular heme to biliverdin, carbon monoxide (CO), and free iron, is represented by three isoforms, HO-1, -2, and -3 encoded by separate genes. HO-3, which in its primary structure resembles HO-2, is marginally active.
5 Evidence has recently accumulated suggesting that CO generated by HO may be a physiological signaling molecule.
6 7 HO may also function as an antioxidant defense mechanism, a possibility suggested on the basis of its marked upregulation in stressed cells,
8 9 including those in tissue subjected to ischemia/reperfusion. One important interpretation of the aforementioned findings is that HO-1 may serve as a key endogenous factor in the adaptation and/or defense against oxidative and cellular stress. Thus, it is reasonable to assume that a relationship may exist between the HO system and endogenous CO production. Keyse and Tyrrell
8 showed that expression of HO-1 is also substantially induced by a variety of molecules causing oxidative stress. Consequently, many investigators have recently focused their attention on the role, function, and regulation of HO-1–related endogenous CO formation in various in vivo and in vitro models. Although the function of HO-1 has recently been extensively studied at the cellular level, comparatively little attention, to our knowledge, has been given to HO-1–related endogenous CO production in the ischemic/reperfused retina. In a previous study, Bak et al.
10 observed a reduction in HO-1 mRNA expression and enzyme activity in ischemic/reperfused myocardium. This finding led us to speculate that the reduction in HO-1 mRNA expression may change the endogenous CO production in ischemic/reperfused retina. If this is the case, HO-1–regulated endogenous CO production and its vasodilator or cytoprotective activity may play a role in the control of reperfusion-induced retinal damage. The overall objectives of the present investigation were to study: (1) formation of endogenous CO levels using gas chromatography, (2) the role of HO-1 protein expression and endogenous CO production on reperfusion, and (3) the effect of flavonoid-rich extract obtained from the seed of sour cherry on HO-1 protein expression, enzyme activity, endogenous tissue CO formation, and tissue Na
+, K
+, and Ca
2+ contents, in ischemic/reperfused retina.